iCeutica Email Format
Pharmaceutical ManufacturingPennsylvania, United States2-10 Employees
iCeutica is a privately held pharmaceutical research and development company based in King of Prussia, Pennsylvania. It uses its SoluMatrix Fine Particle Technology to modify both approved medicines and development-stage compounds, creating new branded therapies through internal development and collaborations with selected partners. Four FDA-approved prescription drugs—Zorvolex, Tivorbex, and Vivlodex for pain, and Yonsa for prostate cancer—utilize this technology, and a pipeline of candidates remains in development. Within the pharmaceutical manufacturing and development landscape, iCeutica operates as a small, privately held firm that collaborates with pharmaceutical developers to bring new therapies to market. The company centers its work on applying its technology to deliver therapies with defined regulatory and commercial paths. A notable corporate development is the appointment of Jyrki Mattila as Chief Business Officer in 2013.